
NYSEHealthcareMedical - Instruments & Supplies
Latest quote
$235.63
−$1.25 · -0.53%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Previous close
$235.63
−$1.25 · -0.53%
Regular session · ET · Market data may be delayed.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Day range
Current $235.63
52-week range
Current $235.63
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
99
Deep Value
Sentiment
72
Bullish
Risk
43
Elevated Risk
Momentum
40
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Day range
Current $235.63
52-week range
Current $235.63
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 5.65B USD | 5.15B USD | 4.69B USD | 4.22B USD | 3.58B USD |
| Cost of goods sold | 2.2B USD | 2.09B USD | 2.03B USD | 1.87B USD | 1.55B USD |
| Gross profit | 3.45B USD | 3.05B USD | 2.66B USD | 2.36B USD | 2.02B USD |
| Research and development | 378.29M USD | 331.28M USD | 307.53M USD | 287.64M USD | 253.58M USD |
| Selling, general, and administrative | 1.12B USD | 991.02M USD | 917.14M USD | 874M USD | 739.37M USD |
| Operating expenses | 1.57B USD | 1.37B USD | 1.34B USD | 1.22B USD | 1.02B USD |
| Interest expense | — | 12.61M USD | 45.71M USD | 47.38M USD | 22.31M USD |
| Depreciation and amortization | 244.15M USD | 235.81M USD | 216.21M USD | 197.56M USD | 193.84M USD |
| Operating income | 1.89B USD | 1.69B USD | 1.32B USD | 1.13B USD | 1B USD |
| Net income | 1.52B USD | 1.4B USD | 1.02B USD | 897.56M USD | 779.44M USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$2.26
2025 complete year+39.5% since 2021
2026 partial: $2.52
$1.62
2,021
$1.72
2,022
$1.84
2,023
$2.02
2,024
$2.26
2,025
$2.52
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Nov 11, 2026 | $0.66Quarterly | Nov 12, 2026 | Dec 17, 2026 |
Dividend | Aug 19, 2026 | $0.66Quarterly | Aug 20, 2026 | Sep 24, 2026 |
Dividend | May 13, 2026 | $0.60Quarterly | May 14, 2026 | Jun 18, 2026 |
Dividend | Feb 11, 2026 | $0.60Quarterly | Feb 12, 2026 | Mar 19, 2026 |
Dividend | Nov 12, 2025 | $0.60Quarterly | Nov 13, 2025 | Dec 18, 2025 |
Dividend | Aug 14, 2025 | $0.60Quarterly | Aug 14, 2025 | Sep 18, 2025 |
Ex-dividend Nov 11, 2026
$0.66
Quarterly
Record Nov 12, 2026 · Payment Dec 17, 2026
Ex-dividend Aug 19, 2026
$0.66
Quarterly
Record Aug 20, 2026 · Payment Sep 24, 2026
Ex-dividend May 13, 2026
$0.60
Quarterly
Record May 14, 2026 · Payment Jun 18, 2026
Ex-dividend Feb 11, 2026
$0.60
Quarterly
Record Feb 12, 2026 · Payment Mar 19, 2026
Ex-dividend Nov 12, 2025
$0.60
Quarterly
Record Nov 13, 2025 · Payment Dec 18, 2025
Ex-dividend Aug 14, 2025
$0.60
Quarterly
Record Aug 14, 2025 · Payment Sep 18, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T66.01B0.06%119.93T JPY0.09%¥113,700-3.19%
Vanguard S&P 500 ETFVOO881.33M0.05%1T USD0.03%$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI831.25M0.05%689.3B USD0.03%$340.02-3.52%
Vanguard Morningstar Mid-Cap ETFVO708.58M0.32%107.4B USD0.03%$76.25-2.22%
iShares Core S&P 500 ETFIVV457.38M0.06%803.41B USD0.03%$693.71-3.52%
State Street SPDR S&P 500 ETFSPY416.39M0.06%756.38B USD0.09%$689.81-3.64%
First Trust Rising Dividend Achievers ETFRDVY393.14M1.65%23.83B USD0.47%$73.57-2.71%
Vanguard Morningstar Growth ETFVUG273.53M0.07%221B USD0.03%$75.69-5.32%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
First Trust Rising Dividend Achievers ETFRDVY
Vanguard Morningstar Growth ETFVUGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.